(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
Live Chart Being Loaded With Signals
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases...
Stats | |
---|---|
今日成交量 | 11.71M |
平均成交量 | 927 342 |
市值 | 5.24M |
EPS | $0 ( 2024-03-12 ) |
下一个收益日期 | ( $0 ) 2024-06-21 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.100 |
ATR14 | $0.00200 (1.10%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-29 | Staskey Norm | Buy | 47 600 | Common Stock |
2024-02-13 | Whitfill Travis | Buy | 15 000 | Common Stock |
2024-02-13 | Staskey Norm | Buy | 3 300 | Common Stock |
2024-02-13 | Salva Francisco D. | Buy | 333 300 | Common Stock |
2023-09-08 | Staskey Norm | Buy | 10 000 | Stock Options (Right To Buy) |
INSIDER POWER |
---|
44.35 |
Last 69 transactions |
Buy: 15 407 806 | Sell: 6 059 394 |
音量 相关性
Azitra, Inc. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Azitra, Inc. 相关性 - 货币/商品
Azitra, Inc. 财务报表
Annual | 2023 |
营收: | $686 000 |
毛利润: | $686 000 (100.00 %) |
EPS: | $-1.630 |
FY | 2023 |
营收: | $686 000 |
毛利润: | $686 000 (100.00 %) |
EPS: | $-1.630 |
FY | 2022 |
营收: | $284 000 |
毛利润: | $284 000 (100.00 %) |
EPS: | $-0.880 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Azitra, Inc.
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。